<DOC>
	<DOCNO>NCT00316277</DOCNO>
	<brief_summary>The purpose study determine whether treatment outcome subject dependent prescription opioid analgesic improve add individual drug counsel prescription buprenorphine/naloxone standard medical management . This examined : ) initial four-week treatment taper ; b ) 12-week stabilization treatment respond successfully initial treatment ; c ) long-term follow-up assessment 1.5 year , 2.5 year , 3.5 year treatment .</brief_summary>
	<brief_title>Prescription Opioid Addiction Treatment Study ( POATS )</brief_title>
	<detailed_description>This randomized 2-phase , open-label ; multi-center study conduct outpatient treatment setting . The main objective study identify effective sublingual buprenorphine/naloxone treatment regimen subject dependent prescription opioids . Phase 1 study assess prevail one-month detoxification practice . This phase ass benefit individual drug counsel short-term treatment paradigm . The second phase study assess benefit individual drug counsel longer-term treatment paradigm participant respond successfully short-term buprenorphine/naloxone treatment . There also long-term follow-up assessment determine outcomes 1.5 year , 2.5 year , 3.5 year treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Narcotics</mesh_term>
	<criteria>18 year old old Physically dependent opioids Meet DSMIV criterion opioid dependence Known allergy sensitivity buprenorphine naloxone Unstable psychiatric disorder Pregnant lactating female Liver function test result great 5 time upper limit normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Opiate Analgesic Dependence</keyword>
</DOC>